All of these may have different functional states: from antitumor proinflammatory M1 (CD68+ CD163-) to protumor antiinflammatory M2 (CD68+ CD163+) macrophages [16], which may explain the discrepancies in reported effects of TAM in HCC. This evidence concerns the gene CD68 and hepatocellular carcinoma.